Alclometasone Side Effects & Health Impacts

Chromium deficiency has been linked to higher cardiovascular risk because low chromium status can impair both glucose and lipid metabolism, driving compensatory hyperinsulinemia that promotes atherogenic changes over time. Studies have reported markedly lower plasma chromium levels in patients with established coronary artery disease compared with healthy controls, suggesting that inadequate chromium may be more common in people with overt atherosclerosis. Mechanistically, chromium insufficiency can worsen insulin resistance, elevate circulating insulin, and contribute to dyslipidemia, supporting the idea that unrecognized chromium deficiency may act as an upstream, modifiable risk factor in the development and progression of cardiovascular disease.

Research: Guallar E, Jiménez FJ, van 't Veer P, Bode P, Riemersma RA, Gómez-Aracena J, Kark JD, Arab L, Kok FJ, Martín-Moreno JM; EURAMIC-Heavy Metals and Myocardial Infraction Study Group. Low toenail chromium concentration and increased risk of nonfatal myocardial infarction. Am J Epidemiol. 2005 Jul 15;162(2):157-64. Bai J, Xun P, Morris S, Jacobs DR Jr, Liu K, He K. Chromium exposure and incidence of metabolic syndrome among American young adults over a 23-year follow-up: the CARDIA Trace Element Study. Sci Rep. 2015 Oct 22;5:15606. Simonoff M. Chromium deficiency and cardiovascular risk. Cardiovasc Res. 1984 Oct;18(10):591-6. Chen J, Kan M, Ratnasekera P, Deol LK, Thakkar V, Davison KM. Blood Chromium Levels and Their Association with Cardiovascular Diseases, Diabetes, and Depression: National Health and Nutrition Examination Survey (NHANES) 2015-2016. Nutrients. 2022 Jun 28;14(13):2687.

Across the lifespan, chronically low calcium intake has been linked to higher blood pressure, in part because calcium plays a key role in vascular smooth‑muscle contraction, sodium handling, and endothelial function. Large epidemiologic studies and randomized trials suggest that individuals with higher dietary calcium intake tend to have modestly lower systolic and diastolic blood pressures and may experience a small but meaningful reduction in risk of stroke and other cardiovascular events. The practical takeaway is that maintaining adequate daily calcium, alongside blood pressure control, exercise, and a heart‑healthy diet, may be an underutilized strategy to support vascular health and reduce long‑term cardiovascular risk.

Research: Kim MH, Bu SY, Choi MK. Daily calcium intake and its relation to blood pressure, blood lipids, and oxidative stress biomarkers in hypertensive and normotensive subjects. Nutr Res Pract. 2012 Oct;6(5):421-8. Hamer O, Mohamed A, Ali-Heybe Z, Schnieder E, Hill JE. Calcium supplementation for the prevention of hypertension: a synthesis of existing evidence and implications for practise. Br J Card Nurs. 2024 Feb 24;19(2):0010. Cheng, L., Lian, J., Ding, Y., Wang, X., Munir, M. A. M., Ullah, S., Wang, E., He, Z., & Yang, X. (2024). Calcium deficiency and its implications for cardiovascular disease and cancer: Strategies for resolution via agronomic fortification. Food Science & Nutrition, 12, 8594–8607.

In adults, chronically low calcium intake can quietly erode skeletal integrity, contributing to osteopenia, osteoporosis, and a higher risk of low‑trauma fractures over time. In children, inadequate calcium (often alongside vitamin D deficiency) impairs normal mineralization of the growing skeleton, leading to rickets with bone pain, deformities, and delayed growth, while in adults the same process manifests as osteomalacia with diffuse bone pain and muscle weakness rather than early fractures. The encouraging reality is that optimizing daily calcium intake, paired with sufficient vitamin D, protein, and weight‑bearing activity, has been shown to improve bone mineral density and meaningfully reduce fracture risk in at‑risk populations.

Research: Bischoff-Ferrari HA, Rees JR, Grau MV, Barry E, Gui J, Baron JA. Effect of calcium supplementation on fracture risk: a double-blind randomized controlled trial. Am J Clin Nutr. 2008 Jun;87(6):1945-51. Cong B, Zhang H. The effects of combined calcium and vitamin D supplementation on bone mineral density and fracture risk in postmenopausal women with osteoporosis: a systematic review and meta-analysis of randomized controlled trials. BMC Musculoskelet Disord. 2025 Oct 8;26(1):928. Heaney RP. Lifelong calcium intake and prevention of bone fragility in the aged. Calcif Tissue Int. 1991;49 Suppl:S42-5. Arnaud, C. D., Sanchez, S. D. The Role of Calcium in Osteoporosis. September 6, 2013. NASA. Lyndon B. Johnson Space Center, Spacelab Life Sciences 1: Reprints of Background Life Sciences Publications. Cairoli E, Aresta C, Giovanelli L, Eller-Vainicher C, Migliaccio S, Giannini S, Giusti A, Marcocci C, Gonnelli S, Isaia GC, Rossini M, Chiodini I, Di Stefano M; Italian Society for Osteoporosis, Mineral Metabolism, Skeletal Diseases (SIOMMMS). Dietary calcium intake in a cohort of individuals evaluated for low bone mineral density: a multicenter Italian study. Aging Clin Exp Res. 2021 Dec;33(12):3223-3235. Uday S, Högler W. Nutritional Rickets and Osteomalacia in the Twenty-first Century: Revised Concepts, Public Health, and Prevention Strategies. Curr Osteoporos Rep. 2017 Aug;15(4):293-302.

In some patients, significant calcium deficiency leading to hypocalcemia can present with acute respiratory manifestations such as laryngospasm and bronchospasm, often in the context of generalized neuromuscular irritability and tetany. Case reports describe episodes of stridor, tightness in the chest, and even acute respiratory distress that improve as ionized calcium levels are corrected. The key clinical implication is that, when otherwise unexplained laryngospasm or bronchospasm occurs alongside perioral numbness, carpopedal spasm, or muscle cramps, prompt evaluation and correction of calcium deficiency can be lifesaving and help prevent recurrent respiratory compromise.

Research: Kennedy J, Pérusse L, Drapeau V, Tremblay A. Cardiorespiratory Fitness in Low Calcium Consumers: Potential Impact of Calcium Intake on Cardiorespiratory Fitness. Nutrients. 2025; 17(19):3138. Kumari A, Nangrani K, Dolkar T, Arora A, Schmidt M. Hypocalcemia Induced Bronchospasm. Cureus. 2022 Jun 26;14(6):e26339. Thongprayoon C, Cheungpasitporn W, Chewcharat A, et al. Serum ionised calcium and the risk of acute respiratory failure in hospitalised patients: a single-centre cohort study in the USA. BMJ Open 2020;10:e034325. Li X, Li Z, Ye J, Ye W. Association of dietary calcium intake with chronic bronchitis and emphysema. J Health Popul Nutr. 2025 Apr 2;44(1):102.

In observational and clinical data, low chromium status has been associated with impaired insulin signaling and may contribute to the long‑term development of type 2 diabetes in susceptible individuals. Chromium acts as a cofactor that helps insulin work more efficiently at its receptor and through downstream signaling pathways, so deficiency can worsen glucose intolerance, increase circulating insulin needs, and exacerbate other metabolic risk factors over time. Population analyses have reported lower odds of having type 2 diabetes among adults who regularly consume chromium‑containing supplements compared with non‑users, though trial results remain mixed, suggesting that chromium repletion may be most relevant in people with documented deficiency or marked insulin resistance rather than as a universal preventive strategy.

Research: Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997 Nov;46(11):1786-91. McIver DJ, Grizales AM, Brownstein JS, Goldfine AB. Risk of Type 2 Diabetes Is Lower in US Adults Taking Chromium-Containing Supplements. J Nutr. 2015 Dec;145(12):2675-82. Chen S, Jin X, Shan Z, Li S, Yin J, Sun T, Luo C, Yang W, Yao P, Yu K, Zhang Y, Cheng Q, Cheng J, Bao W, Liu L. Inverse Association of Plasma Chromium Levels with Newly Diagnosed Type 2 Diabetes: A Case-Control Study. Nutrients. 2017 Mar 17;9(3):294. Alkhalidi F. A comparative study to assess the use of chromium in type 2 diabetes mellitus. J Med Life. 2023 Aug;16(8):1178-1182.

In clinical settings, chromium deficiency has been linked to impaired glucose tolerance and emerging insulin resistance, particularly in patients on long‑term total parenteral nutrition where trace‑element provision is inadequate. Chromium functions as a cofactor that helps insulin signal more effectively at its receptor, so low chromium status can worsen post‑meal glucose excursions and increase insulin requirements despite otherwise unchanged diet or medications. Case reports and small series describe patients with unexplained hyperglycemia and neuropathic symptoms whose glucose tolerance, insulin sensitivity, and sometimes weight trajectory improved after chromium was added back to their nutrition support, underscoring that unrecognized deficiency can masquerade as primary type 2 diabetes or “idiopathic” insulin resistance.

Research: Brown RO, Forloines-Lynn S, Cross RE, Heizer WD. Chromium deficiency after long-term total parenteral nutrition. Dig Dis Sci. 1986 Jun;31(6):661-4. Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997 Nov;46(11):1786-91. Anderson RA, Polansky MM, Bryden NA, Roginski EE, Mertz W, Glinsmann W. Chromium supplementation of human subjects: effects on glucose, insulin, and lipid variables. Metabolism. 1983 Sep;32(9):894-9. Riales R, Albrink MJ. Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. Am J Clin Nutr. 1981 Dec;34(12):2670-8. Anderson RA. Chromium and insulin resistance. Nutrition Research Reviews. 2003;16(2):267-275.

Chromium deficiency has been associated with episodes of confusion and broader cognitive impairment, particularly in patients on long‑term parenteral nutrition who also show impaired glucose tolerance and emerging insulin resistance. Case descriptions suggest that when chromium is extremely low, fluctuating blood glucose and high circulating insulin may contribute to “brain fog,” slowed processing, and difficulty concentrating, sometimes improving after chromium is added back to the nutrition regimen. While large, definitive trials on cognition are lacking, these observations raise the possibility that unrecognized chromium deficiency in people with metabolic instability could quietly worsen cognitive performance and that chromium repletion may help in deficiency states.

Research: Offenbacher, E.G. Chromium in the elderly. Biol Trace Elem Res 32, 123–131 (1992). Krikorian R, Eliassen JC, Boespflug EL, Nash TA, Shidler MD. Improved cognitive-cerebral function in older adults with chromium supplementation. Nutr Neurosci. 2010 Jun;13(3):116-22. Akhtar A, Dhaliwal J, Saroj P, Uniyal A, Bishnoi M, Sah SP. Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway. Inflammopharmacology. 2020 Apr;28(2):385-400. Orhan C, Şahin N, Tuzcu Z, Komorowski JR, Şahin K. Combined oral supplementation of chromium picolinate, docosahexaenoic acid, and boron enhances neuroprotection in rats fed a high-fat diet. Turk J Med Sci. 2017 Nov 13;47(5):1616-1625.

Chromium plays a supporting role in insulin signaling, so insufficient levels have been linked to higher fasting blood sugar and poorer glucose tolerance in both observational and interventional studies. In some trials involving people with type 2 diabetes or impaired glucose tolerance, chromium supplementation has led to modest reductions in fasting glucose and HbA1c, particularly in those with higher baseline blood sugars. Studies suggest that maintaining adequate chromium status may help support healthier blood sugar control and reduce the likelihood of persistent hyperglycemia.

Research: Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997 Nov;46(11):1786-91. Rajendran K, Manikandan S, Nair LD, Karuthodiyil R, Vijayarajan N, Gnanasekar R, Kapil VV, Mohamed AS. Serum Chromium Levels in Type 2 Diabetic Patients and Its Association with Glycaemic Control. J Clin Diagn Res. 2015 Nov;9(11):OC05-8. Riales R, Albrink MJ. Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. Am J Clin Nutr. 1981 Dec;34(12):2670-8. Yin RV, Phung OJ. Effect of chromium supplementation on glycated hemoglobin and fasting plasma glucose in patients with diabetes mellitus. Nutr J. 2015 Feb 13;14:14.

Chromium deficiency has been associated with impaired lipid metabolism, often showing up as elevated triglycerides and reduced HDL cholesterol on standard blood panels. In clinical studies of people with features of metabolic syndrome or type 2 diabetes, chromium supplementation has sometimes produced modest improvements in fasting triglycerides and HDL, particularly in those who were likely chromium-insufficient at baseline. These findings have led researchers to view adequate chromium status as one potential micronutrient factor in maintaining healthier lipid profiles and cardiometabolic resilience.

Research: Lima KV, Lima RP, Gonçalves MC, Faintuch J, Morais LC, Asciutti LS, Costa MJ. High frequency of serum chromium deficiency and association of chromium with triglyceride and cholesterol concentrations in patients awaiting bariatric surgery. Obes Surg. 2014 May;24(5):771-6. Ngala RA, Awe MA, Nsiah P. The effects of plasma chromium on lipid profile, glucose metabolism and cardiovascular risk in type 2 diabetes mellitus. A case - control study. PLoS One. 2018 Jul 5;13(7):e0197977. Bai, J., Xun, P., Morris, S. et al. Chromium exposure and incidence of metabolic syndrome among American young adults over a 23-year follow-up: the CARDIA Trace Element Study. Sci Rep 5, 15606 (2015). Soha Afzal, et al. Chromium Deficiency. StatPearls. June 7, 2024.

In some patients, significant calcium deficiency can culminate in hypocalcemia that presents with neuromuscular irritability, including perioral numbness, carpopedal spasm, frank tetany, and potentially generalized seizures or life‑threatening arrhythmias. Clinical data in children with hypocalcemic seizures suggest that, once acute stabilization is achieved, carefully dosed oral calcium can be as effective as continued intravenous calcium in maintaining serum calcium over the first 24–48 hours, with similar calcium levels and seizure‑recurrence rates reported between groups. The key clinical implication is that prompt recognition and correction of hypocalcemia, followed by an appropriate transition to ongoing oral calcium (and vitamin D when indicated), can help prevent recurrent tetany, seizures, and cardiac instability while longer‑term etiologies of calcium deficiency are addressed.

Research: Han, P., Trinidad, B. J., & Shi, J. (2015). Hypocalcemia-Induced Seizure: Demystifying the Calcium Paradox. ASN Neuro, 7(2). Uday S, Högler W. Nutritional rickets & osteomalacia: A practical approach to management. Indian J Med Res. 2020 Oct;152(4):356-367. Ashwin Reddy S. Ventricular Arrhythmia Precipitated by Severe Hypocalcaemia Secondary to Primary Hypoparathyroidism. Case Rep Cardiol. 2019 Apr 7;2019:4851073. Dhir H, Kumar D, Shah D, Batra P, Ahmed RS, Gupta P. Efficacy of Oral vs. Intravenous Calcium Supplementation for Continuation Therapy in Hypocalcemic Seizures: A Randomized, Controlled Trial. Indian J Pediatr. 2023 May;90(5):433-437.

In both children and adults, chronically low calcium intake can undermine the mineralization of teeth and supporting bone, contributing to enamel hypoplasia, root resorption, and loss of alveolar bone that stabilizes the teeth. Epidemiologic studies have linked lower dietary calcium and dairy intake with higher rates of periodontitis, tooth mobility, and tooth loss, especially in older adults and postmenopausal women. The encouraging piece is that maintaining adequate calcium (alongside vitamin D and good oral hygiene) appears to support healthier periodontal bone and may reduce the risk of dental defects and tooth loss over time.

Research: Nishida M, Grossi SG, Dunford RG, Ho AW, Trevisan M, Genco RJ. Calcium and the risk for periodontal disease. J Periodontol. 2000 Jul;71(7):1057-66. Nascimento GG, Leite FRM, Gonzalez-Chica DA, Peres KG, Peres MA. Dietary vitamin D and calcium and periodontitis: A population-based study. Front Nutr. 2022 Dec 22;9:1016763. Miley DD, Garcia MN, Hildebolt CF, Shannon WD, Couture RA, Anderson Spearie CL, Dixon DA, Langenwalter EM, Mueller C, Civitelli R. Cross-sectional study of vitamin D and calcium supplementation effects on chronic periodontitis. J Periodontol. 2009 Sep;80(9):1433-9. Nishida, M., Grossi, S.G., Dunford, R.G., Ho, A.W., Trevisan, M. and Genco, R.J. (2000), Calcium and the Risk For Periodontal Disease. Journal of Periodontology, 71: 1057-1066.

Low calcium levels overstimulate nerves and muscles, leading to muscle cramps, spasms, and twitching. More significant deficiency can cause tetany, a state of sustained, painful muscle contractions often with carpopedal spasms and tingling around the mouth, hands, and feet. In severe cases, untreated hypocalcemia may progress to breathing difficulties from laryngospasm, seizures, abnormal heart rhythms, and other potentially life‑threatening complications.

Research: Agrawal A, Suryakumar G, Rathor R. Role of defective Ca2+ signaling in skeletal muscle weakness: Pharmacological implications. J Cell Commun Signal. 2018 Dec;12(4):645-659. Uday S, Högler W. Nutritional Rickets and Osteomalacia in the Twenty-first Century: Revised Concepts, Public Health, and Prevention Strategies. Curr Osteoporos Rep. 2017 Aug;15(4):293-302. Basma A. Dahash, et al. Rickets. StatPearls August 7, 2023. Seema M. Policepatil, et al. Hypocalcemic Myopathy Secondary to Hypoparathyroidism.Aloke A, Singh K. An Unusual Presentation of Multifactorial Hypocalcemia as Myopathy: A Case Report. Cureus. 2025 Jul 7;17(7):e87434.

Deficiency of calcium over time can sometimes show up in the skin, hair, and nails as dryness, pruritus, brittle or ridged nails, and diffuse hair shedding, especially when hypocalcemia is more chronic. Clinicians often see these dermatologic changes accompanying other signs of calcium and vitamin D deficiency, such as muscle cramps or bone pain, and they may improve as serum calcium and overall mineral status are normalized. The practical point is that, when patients present with unexplained dry skin, fragile nails, and hair loss, particularly in the setting of poor diet, malabsorption, or endocrine disease, assessing and correcting calcium (and related nutrient) deficiencies can be an important part of restoring healthier skin and adnexal structures.

Research: Lee SE, Lee SH. Skin Barrier and Calcium. Ann Dermatol. 2018 Jun;30(3):265-275. Elias P, Ahn S, Brown B, Crumrine D, Feingold KR. Origin of the epidermal calcium gradient: regulation by barrier status and role of active vs passive mechanisms. J Invest Dermatol. 2002 Dec;119(6):1269-74. Baumann J, Wandrey F, Sacher R, Zülli F. A novel Ca2+ double cone vector system to treat compromised skin. Int J Cosmet Sci. 2024 Apr;46(2):228-238. Bouhmadi, A.E., Fatoiki, F.E., Rachadi, H. et al. Hypocalcemia-related pustulosis: a case report. J Med Case Reports 19, 497 (2025).